What is the primary impact of this filing on Boston Scientific's financial obligations?

The primary impact is the extension of the company's Credit and Security Agreement by one year, to June 28, 2013. This ensures continued access to its credit facility and provides financial flexibility for the near term.

Does this amendment affect Boston Scientific's existing debt levels?

This filing primarily concerns the terms and duration of an existing credit facility and receivables sale agreement, not the incurrence of new debt. The extension of the credit facility implies that the existing credit lines remain available. The actual utilization of these facilities and their impact on debt levels would be detailed in subsequent financial reports like the 10-Q or 10-K.

Are there any immediate cost implications from the fee letter amendment?

The Amended Fee Letter was restated to modify certain fees. While the exact fee changes are not specified in the 8-K, investors should expect potential minor adjustments to the cost of borrowing or servicing the credit facility. The magnitude of these changes would likely be discussed in the company's next quarterly or annual report.

BSX 8-K: Material Agreements & Financial Events

Q: Why were Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi UFJ removed from the agreement?

The filing states these entities were removed as parties to the Credit Agreement and related Transaction Documents. The specific reasons are not detailed, but such changes often occur due to strategic shifts, changes in banking relationships, or streamlining of financial structures. Investors should look for further disclosures or consider the company's broader financial strategy for context.

Summary

Boston Scientific Corporation (BSX) filed an 8-K on July 5, 2012, disclosing an amendment to its Amended and Restated Credit and Security Agreement, originally dated November 7, 2007. This amendment, effective June 29, 2012, extends the term of the Credit Agreement through June 28, 2013. It also removes Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as parties to the agreement and related transaction documents, while making certain technical adjustments. Furthermore, the company amended its Amended and Restated Receivables Sale Agreement with certain wholly-owned subsidiaries and Boston Scientific Funding LLC. These actions, alongside a restated Amended Fee Letter, signal adjustments to the company's financing and securitization arrangements. The extension of the credit facility provides near-term financial stability and flexibility for the company.

Key Highlights

1Extended the term of the Amended and Restated Credit and Security Agreement to June 28, 2013.
2Removed Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch from the Credit Agreement.
3Made technical amendments to the Credit Agreement and the Amended and Restated Receivables Sale Agreement.
4Amended and restated the associated Amended Fee Letter to modify certain fees.
5The amendment addresses a material definitive agreement related to the company's financing structure.
6Confirms continuation of credit facility access for the near term.
7Some lenders involved in the amendment also participate in BSX's separate credit facility from April 2012.

BOSTON SCIENTIFIC CORP 8-K Report, Material Agreement (Jul 6, 2012)

Summary

Key Highlights

Frequently Asked Questions